Oncogenic and Activated Wild-Type ras-p21 Proteins Induce Different Isoforms of Protein Kinase C in Mitogenic Signal Transduction

Journal of Protein Chemistry

Volumn 22, Issue 7-8, 2003, Pages 625-629

  Chie, Lyndon ^a,b   Qu, Yongxia ^a   Chung, Denise ^b   Boutjdir, Mohammed ^a,c,d   Pincus, Matthew R ^a,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e SUNY Downstate Medical Center   (United States)

Author keywords

Insulin; Isoforms; Oocyte maturation; Peptide inhibitors; Protein kinase C (PKC); Ras p21 protein

Indexed keywords

GLUTAMINYLGLUTAMYLVALYLISOLEUCYLARGINYLASPARAGINE; GLUTAMYLALANYLVALYLSERYLLEUCYLLYSYLPROLYLTHREONINE; ISOENZYME; LYSYLLEUCYLPHENYLALANYLISOLEUCYLMETHIONYLASPARAGINE; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C BETA 2; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; PROTEIN P21; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MITOGENICITY; NONHUMAN; OOCYTE MATURATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN; ISOENZYMES; MITOSIS; ONCOGENE PROTEIN P21(RAS); OOCYTES; PEPTIDES; PROTEIN KINASE C; RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; XENOPUS LAEVIS;

ANIMALIA;

EID: 0347992860     PISSN: 02778033     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOPC.0000008727.46554.9e     Document Type: Article

References (12)

1. Barbacid, M. (1987). Ann. Rev. Biochem. 56: 779-827.
2. Birchmeier, C., Broek, D., and Wigler, M. (1985). Cell 43: 615-621.
3. Chung, D. L., Brandt-Rauf, P. W., Weinstein, I. B., Nishimura, S., Yamaizumi, Z., Murphy, R. B., et al. (1992a). Proc. Natl. Acad. Sci. U. S. A. 89: 1993-1996.
4. Chung, D. L., Joran, A., Friedman, F. K., Robinson, R. R., Brandt-Rauf, P. W., Weinstein, I. B., et al. (1992b). Exp. Cell Res. 203: 329-335.
5. Chung, D., Villafania, A., Anwar, K., Amar, S., Rijwani, K., Kung, H-F., et al. (1998). Med. Sci. Res. 26: 147-150.
6. Deshpande, A. K., and Kung, H-F. (1987). Mol. Cell. Biol. 7: 1285-1288.
7. Dominguez, I., Diaz-Meco, M. T., Municio, M. M., Berra, E., Garcia de Herreros, A., Cornet, M. E., et al. (1992). Mol. Cell Biol. 9: 3776-3783.
8. Hu, K., Mochly-Rosen, D., and Boutjdir, M. (2000). Am. J. Physiol. Heart Circ. Physiol. 279: H2558-H2564.
9. Miura, K., Inouye, Y., Nakamori, H., Iwai, S., Ohtsuka, E., Ikehara, M., et al. (1986). Jpn. J. Cancer Res. (Gann) 77: 45-51.
10. Mochly-Rosen, D., and Gordon, A. S. (1998). FASEB J. 12: 35-42.
11. Pincus, M. R., Brandt-Rauf, P. W., Michl, J., and Friedman, F. K. (2000). Cancer Invest. 18: 39-50.
12. Xiao, G., Hu, K., and Boutjdir, M. (2001). Am. J. Physiol. Cell Physiol. 281: C1477-C1486.